Porous silicon microparticle-based cancer vaccines and methods for potentiating anti-tumoral immunity

Research output: Patent

Haifa Shen, (Inventor), Xiaojun Xia, (Inventor), Mauro Ferrari, (Inventor)

Porous silicon (pSi) microparticles (PSM) are disclosed, which provide an important advance in the area of cancer immunotherapeutics and molecular nanomedicine. In particular, potent PSM-based adjuvants are disclosed for dendritic cell-based vaccines compositions, and methods for their use in a variety of cancer immunotherapies. The PSM of the present invention are also useful in developing other types of vaccines, including those not necessarily related to the treatment of cancers, such as vaccines for the treatment of acne, Alzheimer's disease, asthma, atherosclerosis, autoimmune disorders, autoinflammatory disease, celiac disease, colitis, Crohn's disease, diabetes, glomerulonephritis, infectious diseases, inflammatory bowel disease, irritable bowel syndrome, ischemia, Lupus, pelvic inflammatory disease, reperfusion injury, rheumatoid arthritis, sarcoidosis, transplant rejection, and related illnesses.

Original languageEnglish (US)
Patent numberAU2016243027
IPCA61K 39/ 12 A I
Priority date4/1/16
StatePublished - Nov 23 2017

Cite this

Standard

Porous silicon microparticle-based cancer vaccines and methods for potentiating anti-tumoral immunity. / Shen, Haifa (Inventor); Xia, Xiaojun (Inventor); Ferrari, Mauro (Inventor).

IPC No.: A61K 39/ 12 A I. Patent No.: AU2016243027.

Research output: Patent

Harvard

Shen, H, Xia, X & Ferrari, M 2017, Porous silicon microparticle-based cancer vaccines and methods for potentiating anti-tumoral immunity, Patent No. AU2016243027, IPC No. A61K 39/ 12 A I.

APA

Shen, H., Xia, X., & Ferrari, M. (2017). IPC No. A61K 39/ 12 A I. Porous silicon microparticle-based cancer vaccines and methods for potentiating anti-tumoral immunity. (Patent No. AU2016243027).

Vancouver

Shen, H, Xia, X, Ferrari, M, inventors. Porous silicon microparticle-based cancer vaccines and methods for potentiating anti-tumoral immunity. A61K 39/ 12 A I. 2017 Nov 23.

Author

Shen, Haifa (Inventor) ; Xia, Xiaojun (Inventor) ; Ferrari, Mauro (Inventor). / Porous silicon microparticle-based cancer vaccines and methods for potentiating anti-tumoral immunity. IPC No.: A61K 39/ 12 A I. Patent No.: AU2016243027.

BibTeX

@misc{6479e1791c5942bcb163ee4a6df4fb96,
title = "Porous silicon microparticle-based cancer vaccines and methods for potentiating anti-tumoral immunity",
abstract = "Porous silicon (pSi) microparticles (PSM) are disclosed, which provide an important advance in the area of cancer immunotherapeutics and molecular nanomedicine. In particular, potent PSM-based adjuvants are disclosed for dendritic cell-based vaccines compositions, and methods for their use in a variety of cancer immunotherapies. The PSM of the present invention are also useful in developing other types of vaccines, including those not necessarily related to the treatment of cancers, such as vaccines for the treatment of acne, Alzheimer's disease, asthma, atherosclerosis, autoimmune disorders, autoinflammatory disease, celiac disease, colitis, Crohn's disease, diabetes, glomerulonephritis, infectious diseases, inflammatory bowel disease, irritable bowel syndrome, ischemia, Lupus, pelvic inflammatory disease, reperfusion injury, rheumatoid arthritis, sarcoidosis, transplant rejection, and related illnesses.",
author = "Haifa Shen, and Xiaojun Xia, and Mauro Ferrari,",
year = "2017",
month = "11",
day = "23",
language = "English (US)",
type = "Patent",
note = "AU2016243027; A61K 39/ 12 A I",

}

RIS

TY - PAT

T1 - Porous silicon microparticle-based cancer vaccines and methods for potentiating anti-tumoral immunity

AU - Shen,, Haifa

AU - Xia,, Xiaojun

AU - Ferrari,, Mauro

PY - 2017/11/23

Y1 - 2017/11/23

N2 - Porous silicon (pSi) microparticles (PSM) are disclosed, which provide an important advance in the area of cancer immunotherapeutics and molecular nanomedicine. In particular, potent PSM-based adjuvants are disclosed for dendritic cell-based vaccines compositions, and methods for their use in a variety of cancer immunotherapies. The PSM of the present invention are also useful in developing other types of vaccines, including those not necessarily related to the treatment of cancers, such as vaccines for the treatment of acne, Alzheimer's disease, asthma, atherosclerosis, autoimmune disorders, autoinflammatory disease, celiac disease, colitis, Crohn's disease, diabetes, glomerulonephritis, infectious diseases, inflammatory bowel disease, irritable bowel syndrome, ischemia, Lupus, pelvic inflammatory disease, reperfusion injury, rheumatoid arthritis, sarcoidosis, transplant rejection, and related illnesses.

AB - Porous silicon (pSi) microparticles (PSM) are disclosed, which provide an important advance in the area of cancer immunotherapeutics and molecular nanomedicine. In particular, potent PSM-based adjuvants are disclosed for dendritic cell-based vaccines compositions, and methods for their use in a variety of cancer immunotherapies. The PSM of the present invention are also useful in developing other types of vaccines, including those not necessarily related to the treatment of cancers, such as vaccines for the treatment of acne, Alzheimer's disease, asthma, atherosclerosis, autoimmune disorders, autoinflammatory disease, celiac disease, colitis, Crohn's disease, diabetes, glomerulonephritis, infectious diseases, inflammatory bowel disease, irritable bowel syndrome, ischemia, Lupus, pelvic inflammatory disease, reperfusion injury, rheumatoid arthritis, sarcoidosis, transplant rejection, and related illnesses.

M3 - Patent

M1 - AU2016243027

ER -

ID: 38839158